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Background: Nephrometric scoring systems aim to improve the manner in which tumoral complexity is measured
and reported. Each system provides a way to objectively measure specific tumor features that influence technical
feasibility. In this study we aimed to determine how nephrometric scoring systems tailored our approach to the
surgical treatment of localised renal masses.
Methods: Charts of the patients with localised renal tumors, who were managed by either open or robot-assisted
nephron-sparing surgery between May 2010 and June 2012, were retrospectively reviewed. Nephrometric scores [radius,
exophytic/endophytic, nearness, anterior/posterior, location (R.E.N.A.L.) score, preoperative aspects and dimensions used
for anatomic (P.A.D.U.A.) classification and centrality index (C-index)] were calculated based on preoperative imaging
findings. Perioperative data were recorded. Morphometric characteristics of the renal masses were compared.
Additionally, the difference between surgical alternative subgroups in terms of morphometric variables and
the predictive power of each scoring system in determining the details of the surgical plan were investigated.
Furthermore, surgical preferences in different nephrometric categories were compared.
Results: Mean R.E.N.A.L. and P.A.D.U.A. scores of the tumors treated with robotic surgery were significantly lower
than those managed by open surgery. R.E.N.A.L. nephrometry score showed significant differences between most
of the surgical alternative subgroups. P.A.D.U.A. and C-index differences were significant only between robotic
off-clamp and open clamped cases. Tumors that required open conversion had significantly higher mean R.E.N.A.
L. and P.A.D.U.A. score. High R.E.N.A.L. score (cut-off: 6.5) and high P.A.D.U.A. score (cut-off: 7.5) were found to be
significant predictors of the surgical route. Significantly more tumors with moderate R.E.N.A.L. score were managed
through the open approach, while the significant majority of those with low R.E.N.A.L. and low P.A.D.U.A. score were
operated by robotic assistance.
Conclusions: R.E.N.A.L. and P.A.D.U.A. scores influenced our surgical treatment strategy for localized renal masses. High
R.E.N.A.L. and P.A.D.U.A. scores increased the likelihood of an open NSS.
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With recent advances in imaging modalities, the incidental
detection of localised renal cell carcinoma (RCC) has
increased by almost 3.7% per year over the past several
decades [1]. Over 60% of renal masses detected each
year are <4 cm in size [2]. Concurrently, the incidence
of systemic conditions favoring the development of
chronic kidney disease, such as hypertension and
diabetes mellitus, are on the rise [3,4]. Considering the
facts that, partial nephrectomy has similar oncologic
outcomes to that of radical surgery for T1 tumors and
renal insufficiency is associated with adverse cardiovas-
cular outcomes, current evidence suggests that localised
renal cancers are best managed by nephron-sparing
surgery rather than by radical nephrectomy, whenever
technically feasible [5].
Tumoral complexity remains the primary parameter
according to which urologists determine the surgical
approach and treatment strategy regarding renal masses.
Technical details such as the route (open vs. minimally
invasive) and the decision to cease renal blood flow tem-
porarily during mass excision (warm ischemia vs. no
ischemia) are under the influence of tumor characteris-
tics. Morphometric scoring systems (R.E.N.A.L., P.A.D.
U.A. and C-index) have been developed in an effort to
standardize the nomenclature while discussing how
“challenging” the tumor is [6-8]. In this study, we aimed
to determine how nephrometric scoring systems,
tailored our approach in nephron-sparing surgery (NSS).
Methods
Robotic technology has been installed at our hospital in
May 2010 after which we have performed both open and
robot-assisted NSSs. After IRB approval (IRB protocol
no: 2013.189.IRB2.58), we reviewed the charts of the pa-
tients who have undergone NSS (open and robot-
assisted) between May 2010 and June 2012 in our clinic.
Data were retrospectively collected from a prospectively
structured database. All operations were carried out by a
single surgeon (TE), who is highly experienced in open
NSS but has never performed pure laparoscopic surgery.
He has accomplished a direct transition from open to
robot-assisted laparoscopic surgery. Patient characteris-
tics were analyzed, including demographic data, past
medical history, mode of presentation, comorbidities
and American Society of Anesthesiologists (ASA) score.
Radiologic characteristics of the renal masses were
scored retrospectively by a senior radiologist and urolo-
gist according to C-index method [6], R.E.N.A.L.
nephrometry system [7] and P.A.D.U.A. classification [8],
as described elsewhere. The radiologist and the urologist
were blinded with regards to surgical approach and tech-
nical details while they were calculating the morphometric
scores. Based on preoperative radiologic findings, noneof the patients had lymph node involvement or distant
metastasis.
A total of 32 and 23 patients underwent robot-assisted
and open NSS, respectively after the introduction of
robotic technology in our clinic. Coexisting systemic med-
ical problems (Hypertension, diabetes mellitus, etc.) were
present in 38% (n = 21/55) of the patients, while 1 patient
in the robotic group and 3 patients in the open surgery
group had a solitary kidney.
Open nephron-sparing surgery (ONSS) was performed
using the intercostal (between 11th and 12th ribs) extra-
peritoneal flank approach, as previously described [9].
Briefly, after adequate exposure of the kidney, Gerota’s
fascia was opened and perinephritic fatty tissue was
dissected off the renal surface. Ureter and the vascular
pedicle were marked with vessel loops. The decision about
hilar clamping was given perioperatively according to
in-situ findings and preoperative radiologic data. We
did not implement cold-ischemia in any of these open
NSS’s. Tumors were removed via enucleoresection [10].
Bleeding from the tumor bed was controlled with 3/0
polyglactin interrupted sutures and parenchyma was
adapted with 2/0 monofilament running sutures, over a
surgical bolster.
All robot-assisted nephron-sparing surgeries (RANSS)
were performed using the da Vinci surgical system
(Intuitive Surgical, Inc., Sunnyvale, CA) with a 5-port
approach, including two 8 mm ports for robotic in-
struments, one 12 mm port for the robotic scope, and
2 ports for the bedside assistant. RANSS’s were carried
out through the transperitoneal route with the patient
in flank position. After colonic mobilization, Gerota’s
fascia was opened and tumor was adequately exposed.
The decision to clamp renal pedicle was given during
the operation, based on CT and/or MR images and
intraoperative findings. If there was such a need, the
renal artery was occluded with an external vessel loop
secured with a hem-o-lok clip over a silicone tube [11].
After demarcating tumor margins with electrocautery,
resection was carried out using cold-scissors. All
tumors were enucleoresected leaving a minimal margin
of normal parenchyma. Tumor bed was oversewn with
3/0 polyglactin sutures (in case of pelvicalyceal viola-
tion) and parenchyma was approximated using the
“sliding clip” technique.
Operative data consisted of total operative time, esti-
mated blood loss (EBL), warm-ischemia time (WIT) and
adverse events. Final pathology reports were analyzed
and thirty-day Clavien grade 2 and higher complications
were recorded [12].
We compared the morphometric characteristics of the
renal masses managed by open and robot-assisted NSS.
In addition, we investigated if nephrometric scores dif-
fered significantly between surgical alternative subgroups
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off-clamp). Furthermore, surgical preferences in different
nephrometric categories were compared. We also tested
the predictive power of each scoring system in determin-
ing the details (route, hilar clamping) of the surgical plan.
Statistical calculations were performed with the t test,
Fisher’s exact test and univariate linear models which
were provided by the commercially available software (SPSS
version 20).Results
Demographic data of the patients enrolled to the study
is shown in Table 1. Patients in the open surgery group
were significantly older (p = 0.049). However, the differ-
ence between mean ASA scores was insignificant.
Majority (72% in the robotic surgery group vs. 82.6% in
the open surgery group, p = 0.52) of the tumors were
discovered incidentally on imaging studies that were or-
dered for non-urologic complaints.
Tumor size ranged between 0.5 – 15 cm and the mean
diameter did not differ significantly between two groups.
Mean R.E.N.A.L. and P.A.D.U.A. scores were signifi-
cantly higher in the open surgery group (Table 1).
Operative findings are summarized in Table 1. Robot-
assisted operations lasted significantly longer than their
open counterparts. Although mean EBL amount was
higher in the open surgery group, transfusion rate was
higher in the robot-assisted surgery group. However,
these differences were not statistically significant. Renal
hilum was clamped in 6 (26%) and 8 (25%) patients in
the open and robotic groups, respectively. The difference
between mean warm-ischemia times was insignificant.Table 1 Differences between open and robotic groups in term
perioperative outcomes
RANSS
Mean age (years) 51.5 ± 13.4 (rang
Gender (female/male) 9/23
Mean A.S.A. score 1.47 ± 0.51 (rang
Mean tumor size (cm) 4.25 ± 3.0 (range
Tumor morphometry (mean values) R.E.N.A.L. 6.15 ± 2.04 (rang
P.A.D.U.A. 7.53 ± 1.81 (rang
C-index 1.49 ± 0.43 (rang
Mean operative duration (min) 154.3 ± 55.3 (ran
Mean EBL (ml) 189.1 ± 165.4 (ra
Transfusion (n) 5 (15.62%)
Hilar clamping (n) 8 (25%)
Mean WIT (min) 20.62 ± 2.19 (ran
Mean duration of hospitalization (days) 4.06 ± 1.29 (rang
30-day Clavien grade≥ 2 complications (n) 6 (18.75%)Lengths of hospital stay and complication rates were
similar between groups. Blood transfusion (n = 3),
double-j catheter insertion because of urinary extrava-
sation (n = 1) and nasogastric tube insertion due to
ileus (n = 2) were the recorded Clavien grade ≥ 2 com-
plications in the robotic group. One patient in the
ONSS group, who had a 9 cm solid mass bearing soli-
tary kidney, suffered from a total of 3 Clavien grade ≥ 2
complications (blood transfusion, double-j insertion,
temporary hemodialysis) postoperatively. Blood transfu-
sion in another patient was the remaining Clavien grade ≥
2 complication in the open surgery group.
Open conversion (15.6%, n = 5) was necessary because
of tumor size in 2, difficulty in dissection in 1 and
uncontrollable bleeding in 2 cases. Converted cases had
significantly higher mean R.E.N.A.L. (9.0 ± 0.71 vs. 5.63 ±
1.76, p = 0.0002) and P.A.D.U.A. scores (9.6 ± 0.89 vs.
7.15 ± 1.68, p = 0.003) than the cases, which were accom-
plished with robotic assistance. However, the difference
was insignificant in terms of mean C-index value (1.42 ±
0.42 vs. 1.50 ± 0.44, p = 0.698).
Histopathologic diagnosis was renal cell carcinoma
(RCC) in 42 patients, (76%) with clear cell variant being
the most common (n = 32, 76%) subtype. Angiomyolipoma
(n = 5) represented the most frequently diagnosed benign
lesion. Surgical margins were free of tumoral infiltration
in all patients.
The relationship between surgical alternatives and
nephrometric data is schematized in Figure 1. Tumors
managed with open NSS under warm ischemia, had the
highest mean R.E.N.A.L. and P.A.D.U.A. score and the
lowest mean C-index value (p < 0.05). Surgical alternative
subgroups showed significant differences between eachs of demographic data, tumor characteristics and
ONSS P value
e = 30–76) 58.5 ± 10.25 (range = 31–82) 0.049
8/15 N.A.
e = 1–2) 1.43 ± 0.59 (range = 1–3) 0.819
= 1.2-15) 4.27 ± 2.27 (range = 0.5-9.5) 0.976
e = 4–10) 8 ± 1.5 (range = 5–10) 0.0006
e = 6–11) 8.56 ± 1.44 (range = 6–11) 0.027
e = 0.7-2) 1.25 ± 0.5 (range = 0–2) 0.066
ge = 70–270) 126.09 ± 33.51 (range = 75–220) 0.034
nge = 100–1000) 239.13 ± 102.2 (range = 100–500) 0.204
1 (4.34%) 0.383
6 (26.08%) 1.0
ge = 16–24) 16.50 ± 5.21 (range = 12–23) 0.064
e = 3–7) 4.6 ± 1.75 (range = 3–10) 0.188
4 (17.39%) 0.988
Figure 1 Morphometric data of the renal tumors managed with
open or robotic approach under ischemic and non-ischemic
conditions. ★: Significant differences between robotic off-clamp vs.
open clamped cases in terms of R.E.N.A.L. (5.96 ± 1.97 vs. 9.0 ± 0.63,
p = 0.0009), P.A.D.U.A. (7.38 ± 1.76 vs. 9.5 ± 0.84, p = 0.008) and C-index
(1.52 ± 0.40 vs. 1 ± 0.63, p = 0.017) values. ♦: Significant difference
between robotic off-clamp vs. open off-clamp cases in terms of
R.E.N.A.L. score (5.96 ± 1.97 vs. 7.65 ± 1.58, p = 0.005). +: Significant
difference between robotic clamped vs. open clamped cases in
terms of R.E.N.A.L. score (6.75 ± 2.31 vs. 9.0 ± 0.63, p = 0.04).
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A.D.U.A. and C-index differences were significant only
between the tumors dealt with non-ischemic robot-assisted
surgery and open surgery under ischemic conditions
(Figure 1).
After investigating the management strategy of the
tumors in each R.E.N.A.L. and P.A.D.U.A. category (low,
moderate, high), it was found out that, significantly more
patients with low R.E.N.A.L. score and low P.A.D.U.A.
score were managed with robot-assisted surgery whereas
the majority of those with moderate R.E.N.A.L. score were
treated with open NSS (Table 2).
On univariate analyses, R.E.N.A.L. and P.A.D.U.A. scores
were found to be significant predictors of the operative
route (open vs. robot-assisted). R.E.N.A.L. score (cut-off
value: 6.5) predicted the likelihood of open route with a
sensitivity of 82.6% and specificity of 62.5% (Figure 2).
P.A.D.U.A. score (cut-off value: 7.5) predicted the same
outcome with a sensitivity of 82.6% and specificity ofTable 2 Number of patients in each R.E.N.A.L. and P.A.D.U.A. ca
ONSS
R.E.N.A.L. score (n) Low 4
Moderate 16
High 3
P.A.D.U.A. score (n) Low 4
Moderate 11
High 8
R.E.N.A.L. system; low score: 4–6, moderate score: 7–9, high score: 10–12.
P.A.D.U.A. system; low score: 6–7, moderate score: 8–9, high score: ≥10.59.4% (Figure 3). None of the morphometric systems
predicted the status of renal perfusion during enucleor-
esection (clamped vs. off-clamp) with adequate statistical
significance.Discussion
Nephron-sparing surgery has been accepted as the ideal
treatment of localised RCC, given the similar oncological
outcomes to that of radical surgery [13-17]. However,
imaging studies may sometimes question the feasibility
of NSS mostly because of either the size or the localization
of the tumor. Moreover, without a structured and repro-
ducible system for describing the relevant renal mass
anatomy, treatment decisions will vary, depending on
urologist’s training, biases, comfort levels, and individual
experience.
Recently, three different scoring systems were devel-
oped to serve as a common vocabulary when discussing
anatomic geometry and complexity of renal masses.
Preoperative aspects and dimensions used for anatomic
(P.A.D.U.A.) classification and R.E.N.A.L. (radius, exo-
phytic/endophytic, nearness, anterior/posterior, location)
scoring systems involve similar components and method-
ology, enabling a comprehensive description of the tumor
size, polarity, anterior/posterior location and proximity to
the collecting system [7,8]. The centrality index (C-index),
however, is a completely different system that involves a
relatively complex mathematical concept and character-
izes tumor centrality based on the ratio of the distance
between the tumor and kidney center and tumor radius
[6]. Currently, there is no clear consensus favoring the
utility of any score or index over the others.
Nephrometric scoring systems have also been associated
with certain measures of operative complexity such as
ischemia time and complication rates. Waldert et al. re-
ported a significant association between high P.A.D.U.A.
scores (≥ 10) and increased WIT (22 vs. 34 minutes) [18].
Similarly, Simmons et al. stated that tumors with a C-
index of ≤ 1 had a 2.3-fold risk of prolonged WIT (≥
35 minutes) compared with tumors with a C-index ≥ 1 [6].
Each unit increase in R.E.N.A.L. score was associated withtegory operated by either open or robot-assisted surgery







Figure 2 Receiver operating characteristics of R.E.N.A.L. score
with regard to surgical route prediction (Cut-off: 6.5, AUC:
0.755, p = 0.001, sensitivity: 82.6, specificity: 62.5).
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study conducted by Bruner et al. [19]. Another study
highlighted the significant increase in complication
rates with increasing P.A.D.U.A. score among patients
undergoing partial nephrectomy. Tumors with scores
of 8 to 9 had a hazard ratio of 14.5 for postoperativeFigure 3 Receiver operating characteristics of P.A.D.U.A. score
with regard to surgical route prediction (Cut-off: 7.5, AUC:
0.673, p = 0.028, sensitivity: 82.6, specificity: 59.4).complications compared with tumors with scores of 6 to
7. Tumors scoring ≥ 10 had a hazard ratio of 30.6 [8].
Apart from the documented power in predicting peri-
operative outcomes, these scoring systems also have the
potential to influence surgical preferences, which cov-
ered the scope of this article. According to our results,
mean R.E.N.A.L. and P.A.D.U.A. scores of the tumors
managed by robotic assistance were significantly lower
than those treated by open surgery. Although being
lower in tumors managed by open approach, C-index
values did not exhibit a statistically significant differ-
ence between open and robotic groups (Table 1). These
differences may be due to selection biases, with more
peripheral, exophytic, and smaller tumors being scheduled
for robot-assisted surgery. However, these are the initial
robot-assisted nephron sparing surgeries performed in our
clinic by a surgeon who is experienced in open surgery.
Tumor size, estimated blood loss amounts and trans-
fusion rates, which would be considered among the fac-
tors indirectly reflecting how “tough” the tumor was,
did not differ significantly between open and robotic
groups. Robot-assisted nephron-sparing surgeries lasted
significantly longer than their open counterparts. How-
ever, this difference may not be regarded as a sign of
tumoral complexity since recorded time in robotic sur-
geries included the “docking” maneuvers.
In our practice, the decision to occlude renal ped-
icle is given during the operation. Therefore, it might
be regarded as an “in-vivo” validation of the pre-
operative morphometric information. Moreover, inter-
rupting renal perfusion temporarily constitutes a
major clinical concern since longer warm ischemia
time has been associated with acute renal failure, de-
creased glomerular filtration rate and de-novo chronic
kidney disease [20]. In order to clarify this issue we
investigated the differences between surgical choice
subgroups in terms of morphometric scores. We
found a statistically significant difference between ro-
botic off-clamp cases and open clamped cases with
regard to each morphometric score (R.E.N.A.L., P.A.
D.U.A. and C-index, Figure 1). However, only R.E.N.
A.L. score demonstrated significant differences across
most of the studied surgical alternative subgroups (ro-
botic off-clamp vs. open off-clamp and robotic
clamped vs. open clamped) (Figure 1).
Open conversion during minimally invasive surgery
might be regarded as another way of expressing the
challenging nature of the tumor being handled. In
our series, those tumors, for which open conversion
was inevitable, had significantly higher mean R.E.N.A.
L. and P.A.D.U.A. scores than those who were suc-
cessfully treated in a minimally invasive fashion.
On univariate analyses, P.A.D.U.A. and R.E.N.A.L.
scores demonstrated sufficient predictive power in
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sected. High R.E.N.A.L. score (cut-off value: 6.5) and
high P.A.D.U.A. score (cut-off value: 7.5) predicted the
likelihood of an open NSS, with adequate statistical
power. This finding was complemented by the significant
difference between the number of patients in low, mod-
erate R.E.N.A.L. and low P.A.D.U.A. categories with re-
gard to the route that has been preferred for NSS
(Table 2). In a similar study including more than 400
patients undergoing NSS, Canter et al. reported that pa-
tients undergoing open surgery had a significantly higher
mean R.E.N.A.L. score, than those managed with
minimally-invasive NSS (8.19 vs. 6.62, p < 0.0001) [21]. Re-
cently, Rosevear et al. confirmed the predictive power of
R.E.N.A.L score in terms of operative approach selection,
with significantly more patients with low and high scores
undergoing partial and radical nephrectomy, respectively
in their cohort of 249 patients [22].
However, our findings do not mean that we preferen-
tially use the R.E.N.A.L. or the P.A.D.U.A. system for pre-
operative morphometric assessment. Based on the
available literature, there is no clear advantage of one scor-
ing system over the others regarding surgical preferences
and perioperative outcome. As the number of patients in
each sub-category increase, the C-index differences that
were stated as insignificant might gain statistical signifi-
cance. Therefore, it is hard to draw strict conclusions about
the superiority of R.E.N.A.L. or P.A.D.U.A. scoring systems
based on our results.
Our study is unique in that it focuses on the utility of
morphometric scoring systems in tailoring the surgical ap-
proach rather than perioperative outcomes or oncologic re-
sults. Moreover, only nephron-sparing surgeries performed
by a single surgeon through the open or robot-assisted lap-
aroscopic route were taken into consideration. At last but
not the least, we tested the discriminative power of all
three scoring systems that are currently being utilized
across the globe. However, this data reflects the experience
of a single surgeon, who is proficient in open NSS and cur-
rently in the initial phase of the learning curve for robotic
NSS, which may limit the reproducibility of our findings.
Our statistical findings are also handicapped by the
retrospective study design and small sample size. An-
other criticism is the lack of strictly defined indications
about the details of the surgical strategy. Route of ac-
cess and the decision to clamp the renal hilum during
enucleoresection depended on a variety of factors such as
patient profile (general health status, comorbidities),
tumor characteristics (size, location, complexity) and sur-
geon preference. In the early days of the robotic era in our
hospital, smaller (cT1a), cortical and exophytic tumors
that were located anteriorly, below or above the hilar plane
were scheduled for robot-assisted NSS while more compli-
cated tumors (hilar, cT1b-T2, mostly endophytic) weremanaged by open NSS in order to ensure a reasonable
warm ischemia time. However, as our experience grew, we
started doing robot-assisted NSS for more challenging tu-
mors. This selection bias, which can be understandable
within the context of the learning curve, should be consid-
ered while interpreting our results. Future prospective
studies enrolling higher number of patients will more
precisely highlight the importance of adapting preopera-
tive morphometric evaluation into routine clinical
practice.Conclusions
R.E.N.A.L. and P.A.D.U.A. systems influenced the way we
handled localised renal masses. High R.E.N.A.L. and P.A.
D.U.A. scores increased the likelihood of an open NSS.
Although R.E.N.A.L. score differed significantly between
surgical alternative subgroups, it did not exhibit sufficient
statistical power to be a significant predictor of pedicle
clamping during NSS. Morphometric evaluation, espe-
cially R.E.N.A.L. and P.A.D.U.A. systems, seem to have
a clear impact on the decision-making process for the
surgical treatment of localised renal tumors. Further
prospective studies enrolling higher number of patients
may establish the actual predictive power of morphometric
scoring systems in the surgical planning of renal masses.
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